Whole Brain Radiation Therapy (WBRT)

RADIATION3 trials

Sponsors

Spectrum Pharmaceuticals, Inc, University of California, San Francisco, Baptist Health South Florida

Conditions

Brain MetastasesBreast CancerMetastasesPrimary Central Nervous System LymphomaRefractory CancerRelapsed CancerSecondary Central Nervous System Lymphoma

Phase 2

Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas

RecruitingNCT05681195

Baptist Health South FloridaPrimary Central Nervous System Lymphoma, Refractory Cancer, Relapsed Cancer +1

Start: 2024-04-25End: 2033-02-01Target: 15Updated: 2026-03-03

Phase 3

Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer

CompletedNCT00083304

Spectrum Pharmaceuticals, IncBreast Cancer, Metastases

Start: 2004-02-29End: 2007-06-30Updated: 2013-05-10

Unknown Phase

Neurocognitive Outcomes In Patients Treated With Radiotherapy For Five Or More Brain Metastases

WithdrawnNCT01731704

University of California, San FranciscoBrain Metastases

Start: 2012-12-31End: 2018-12-31Updated: 2017-03-14

Related Papers

Efficacy of pemetrexed-based regimens in primary central nervous system lymphoma: A single-center experience.

Journal of Clinical Oncology2025-05-281 citations

Whole brain radiotherapy versus stereotactic radiosurgery for 4-10 brain metastases: a phase III randomised multicentre trial.

2017-07-2539 citations